Felipe Pantoja Mesquita

Next-generation CAR-T therapy for malignant brain tumors: latest updates from the 2026 AACR Annual Meeting

The 2026 AACR Annual Meeting showcased rapid progress in chimeric antigen receptor (CAR) T-cell therapy for malignant brain tumors. This correspondence synthesizes 12 clinical and translational abstracts addressing early efficacy, resistance mechanisms, target discovery, and next...